Home >> Tag Archives: Agendia—

Tag Archives: Agendia—

Agendia, partners land $6.8 million for CRC research

Dec. 28, 2015—Dutch genomic diagnostics company Agendia and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer. The grantees will test therapies matched to the molecular subtype of each patient’s tumor to see if they are more effective than current therapies not keyed to a tumor’s subtype. Agendia technology will be used ...

Read More »